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ABSTRACT
Chikungunya is a mosquito-borne virus that
has shown increased prevalence in the
Caribbean since October 2013. There have
been several outbreaks throughout Asian and
African countries over the past few decades with
global travel and tourism having a major impact
on the further spread of this disease. Improved
policies and practices for preventative measures
and epidemiological surveillance must be
implemented to prevent the continued
transmission of chikungunya.
Keywords: Aedes aegypti; Aedes albopictus;
Caribbean; Chikungunya virus (CHIKV);
Dengue fever; Jamaica; Saint Martin
INTRODUCTION
A member of the Togaviridae family, infection
with the chikungunya virus (CHIKV) has
emerged as a major public health concern,
resulting in outbreaks of fever and debilitating
arthralgia in the Caribbean and globally [1]. The
first autochthonous (native) transmission of
CHIKV in the Caribbean was confirmed in
December 2013 on the French island of Saint
Martin [2]. Rapid spread and local transmission
of CHIKV occurred in the Caribbean and the
Americas within 9 months (Fig. 1). This has
resulted in 651,344 suspected and 9,182
laboratory-confirmed chikungunya cases in the
Caribbean and the Americas as reported by the
Centers for Disease Control and Prevention [3].
The effective management of the rapid spread of
chikungunya is integrally related to the
geographic distribution and re-emergence of
competent mosquito vectors, evolving CHIKV
genotypes, susceptible human populations,
environmental influences, and social
mobilization [4]. Understanding the
contribution of these factors is important to
improving the control of the global transmission
of this disease.
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There are three distinct CHIKV genotypes: West
African, East Central South African [ECSA; or
Indian Ocean lineage (IOL)], and Asian [1, 5, 6].
These genotypes represent the evolution of the
virus in keeping with the geographic
distribution over the years. In Africa, this virus
is transmitted through enzootic (sylvatic) and
urban (human–mosquito cycle) cycles among
non-human and human primates by Aedes
mosquitoes species. Previous authors report
the probable existence of the CHIKV in Africa
for hundreds of years, with the first suspected
epidemic documented in 1779 [7]. Subsequent
reports included outbreaks in Nigeria (1964),
the Ivory Coast (1981), and Senegal (1983)
associated with the West African strain [6].
The resurgence of chikungunya in the
twentieth century was first documented in
1953, in the Newala District of Tangaiynika
(Tanzania) [8]. The CHIKV continued to spread
through the suspected vectors Aedes furcifer/
Aedes cordellieri, to other South African
countries, inclusive of Rhodesia (Zimbabwe;
1961, 1962, and 1971) [9].
Epidemics associated with the ECSA lineage
subsequently occurred in Cameroon (2006) and
Gabon (2007) with Aedes africanus and Aedes
albopictus reported as the principal vectors,
respectively [10]. In Gabon in 2007,
concurrent CHIKV and dengue fever epidemics
were also experienced, with CHIKV
transmission linked to the A. albopictus
mosquito [11].
Fig. 1 Introduction of chikungunya to the Caribbean by epidemiological week ﬁrst reported—December 2013 to August
2014. Data from PAHO/WHO statistics [26]
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The IOL is thought to have evolved from the
ECSA genotype [7]. The IOL strain originated in
coastal Kenya in 2004 and 2005 (affecting 75%
of the Lamu Island’s population, via the vector
Aedes aegypti) and then spread to the Reunion
Island (affecting one-third of the population)
and was subsequently introduced to other
islands of the Indian Ocean and continental
India, via the vector A. albopictus [1, 5–7, 12].
The CHIKV IOL then spread onward to South
East Asia [12].
It is believed that the 2007 outbreak in Italy
was initiated through the importation of the
CHIKV by a traveler from Reunion Island [13].
Local transmission in Reunion Island was then
established with A. albopictus as the vector [13].
Other countries in which international travel
facilitated the spread of CHIKV included France
(from travelers from Reunion Island; 77%),
Comoros (14%), and Mauritius (9%) [14].
Autochthonous transmission in France,
however, was not detected until the year 2010,
in association with A. albopictus [15]. Studies
have reported a high efficiency of transmission
of CHIKV in the temperate climates by the A.
albopictus species [15].
There are several Aedes species which are
competent in the transmission of the CHIKV,
with A. aegypti and emerging populations of A.
albopictus identified as responsible vectors in
Asia [16]. The Asian strain identified in Thailand
in 1958 was transmitted by the suspected
vector, A. aegypti [1]. This Asian strain was also
reported in outbreaks in India (1962–1965) and
Southeast Asia (1958–1960 and 1962–1964),
also in association with the A. aegypti
mosquito [17]. Epidemics of the 1980s and
1990s in Southeast Asian countries
(Philippines, Thailand, Myanmar, and
Indonesia) were associated with the Asian
endemic/epidemic CHIKV lineage. Since then,
the Asian endemic/epidemic CHIKV lineage has
continued to circulate sporadically, transmitted
primarily among humans by A. aegypti and was
again documented in the 2006 outbreak in
Malaysia [1, 7].
Emergence of an IOL strain with resulting
replacement of the endemic Asian strain
occurred during the Southeast Asia epidemics
of 2006–2009 [1, 7]. It is thought that the E1
envelope glycoprotein mutation of the endemic
Asian genotype resulted in the decreased
adaptability of the CHIKV to A. albopictus,
with decreased transmission, and the
facilitation of CHIKV evolution and strain
replacement [18].
THE CARIBBEAN
The Caribbean region continues to encounter
challenges with the control of mosquito
populations including A. aegypti and other
Aedes species. The Aedes mosquito was
introduced to the Caribbean through the
African slave trade [19]. Following its
introduction, a significant increase in the A.
aegypti population density was associated with
the intercontinental exchange activities of the
Second World War [20]. Public health
interventions of National Health Ministries and
the Pan American Health Organization in the
1950s and 1960s successfully reduced A. aegypti
vector indexes by 1972 [19]. This success,
however, was short lived and the re-infestations
of the Latin American and Caribbean regions by
A. aegypti in the late 1970s was accompanied by
the introduction of A. albopictus in the early
1980s to some Caribbean countries [19].
Although both A. aegypti and A. albopictus may
be found in the Caribbean, A. aegypti remains the
principal vector responsible for the transmission
of CHIKV and dengue in this region [21].
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To date, the CHIKV lineage identified in the
2014 Caribbean outbreak belongs to the old
Asian lineage [6]. The presence of the Asian
lineage CHIKV, compounded by a naı¨ve
Caribbean population and high prevalence of
A. aegypti, makes the probability of
establishment of endemicity of chikungunya
in the Caribbean high. This risk of
establishment of endemicity extends to most
tropical and subtropical regions of Latin
America areas and the southern USA, which is
presently experiencing challenges with A.
aegypti re-infestation.
In the months preceding the Caribbean’s
first case, China and the Philippines accounted
for 27.5% of travelers into the Caribbean [22].
There were ten cases reported in Spain from
travelers from Haiti and Dominica Republic
during April to June 2014 [23]. The expansion
of the CHIKV to North and South America from
the Caribbean is of great concern. Khan et al.
[22], in their review of air travel from the
Caribbean, noted that the final destination of
52.1% of international travelers from the
chikungunya-infected Caribbean territories was
the USA [22]. The most likely cities to be
travelled to from the Caribbean were New
York (13.8%), Paris (11.7%), Miami (7.8%) and
San Juan, Puerto Rico (3.9%) [22]. It is expected
that the change of climatic conditions,
compounded by the increase of the warmer
weather in temperate zones, will facilitate the
further spread of this disease. The months June
through to November are designated as the
‘‘hurricane season’’ in the Caribbean, or ‘‘the
wet season’’. The wet season has been shown to
be associated with the increased breeding of the
A. aegypti mosquitos [24].
Florida reported its first two cases of
autochthonous CHIKV transmission in July
2014 and, as of September 9, 2014, remains
the only US state with autochthonous
transmission [25]. Florida now has eight cases
of local transmission and 184 travel-associated
laboratory-confirmed chikungunya cases as
reported to ArborNET [25].
The impact of the introduction of CHIKV
into the Caribbean region, a known tourist
destination exchange of an estimated 20
million persons annually of which 9 million
are US residents, remains to be seen [22]. The
acquisition of CHIKV by travelers to the
Caribbean enhances the spread to neighboring
Caribbean countries and globally [25]. As of
epidemiological week 35, among the Caribbean
countries affected, those with the highest
incidence rates (incidence/100,000 population)
include: Guadeloupe (16,465), Martinique
(15,087), Saint Martin (French part 13,401),
Saint Barthelemy (11,707), Dominica (5,068),
Dominican Republic (4,128), and Haiti (627)
(Fig. 1) [26].
The emergence of chikungunya in the
Caribbean unfolds a story of the dynamic
evolution and interaction of microbes and risk
factors underlying the determinants of health.
The interaction of economic trade and its role
in the transmission of vectors and infectious
agents needs to be reviewed and policies
reinforced and implemented. The
management of this disease extends beyond
chikungunya to all potential arboviral diseases.
Continued education to increase the
awareness of this disease is needed to curtail
the population growth of mosquitoes and to
mitigate the spread of chikungunya by travelers
to the USA and other regions. Improved
awareness of the epidemiology and clinical
manifestations will enhance patient
management and timely reporting to
respective authorities. Preventative measures
and epidemiological monitoring of the
evolving CHIKV epidemic in the Caribbean
must be improved and sustained.
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